Literature DB >> 19089635

Long-term disorders of behavior in rats induced by administration of tumor necrosis factor during early postnatal ontogenesis.

O E Zubareva1, V M Klimenko.   

Abstract

The proinflammatory cytokine tumor necrosis factor alpha (TNFalpha) is one of the main mediators of neuroimmune interactions. Increased production of TNFalpha in nerve and immune system cells occurs in infectious diseases, traumas, ischemia, and hypoxia. The present study addressed the role of TNFalpha in the formation of behavior during early postnatal ontogenesis. TNFalpha was given to rats during the third week of life and behavior was tested at ages 1.5 and 3 months using the open field test and the elevated plus maze test. Experimental rats differed from controls in terms of changes in orientational behavior on testing at 1.5 months and an increase in anxiety on testing at 1.5 and 3 months. The different roles of proinflammatory cytokines in the brain at the early stages of ontogenesis are discussed.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19089635     DOI: 10.1007/s11055-008-9090-6

Source DB:  PubMed          Journal:  Neurosci Behav Physiol        ISSN: 0097-0549


  22 in total

Review 1.  Regulation of oligodendrocyte development.

Authors:  D M Orentas; R H Miller
Journal:  Mol Neurobiol       Date:  1998-12       Impact factor: 5.590

2.  IL-1beta, IL-6 and TNF-alpha and outcomes of neonatal hypoxic ischemic encephalopathy.

Authors:  Hany Aly; Mohamed T Khashaba; Mostafa El-Ayouty; Osman El-Sayed; Bothina M Hasanein
Journal:  Brain Dev       Date:  2005-09-21       Impact factor: 1.961

3.  Predictive value of plasma and cerebrospinal fluid tumour necrosis factor-alpha and interleukin-1 beta concentrations on outcome of full term infants with hypoxic-ischaemic encephalopathy.

Authors:  N Oygür; O Sönmez; O Saka; O Yeğin
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1998-11       Impact factor: 5.747

4.  Neonatal encephalopathy: association of cytokines with MR spectroscopy and outcome.

Authors:  Agnes I Bartha; Audrey Foster-Barber; Steven P Miller; Daniel B Vigneron; David V Glidden; A James Barkovich; Donna M Ferriero
Journal:  Pediatr Res       Date:  2004-10-20       Impact factor: 3.756

5.  Secretion of tumor necrosis factor during fetal and neonatal development of the mouse: ontogenic inflammation.

Authors:  K Yamasu; H Onoe; G Soma; H Oshima; D Mizuno
Journal:  J Biol Response Mod       Date:  1989-12

6.  Expression of cytokines during glial differentiation.

Authors:  T Mizuno; M Sawada; A Suzumura; T Marunouchi
Journal:  Brain Res       Date:  1994-09-05       Impact factor: 3.252

7.  Synergy between tumor necrosis factor alpha and interleukin-1 in the induction of sickness behavior in mice.

Authors:  R M Bluthé; M Pawlowski; S Suarez; P Parnet; Q Pittman; K W Kelley; R Dantzer
Journal:  Psychoneuroendocrinology       Date:  1994       Impact factor: 4.905

8.  General pharmacology of recombinant human tumor necrosis factor. 2nd communication: effects on central nervous system functions.

Authors:  S Kurumiya; Y Miura; K Nakatsuji; M Dodo; M Hori; T Ito
Journal:  Arzneimittelforschung       Date:  1990-02

9.  Brain injury induced by intracerebral injection of interleukin-1beta and tumor necrosis factor-alpha in the neonatal rat.

Authors:  Zhengwei Cai; Shuying Lin; Yi Pang; Philip G Rhodes
Journal:  Pediatr Res       Date:  2004-06-16       Impact factor: 3.756

10.  Apoptosis of oligodendrocytes in secondary cultures from neonatal rat brains.

Authors:  Wendy Cammer
Journal:  Neurosci Lett       Date:  2002-07-19       Impact factor: 3.046

View more
  1 in total

1.  Reversal of established traumatic brain injury-induced, anxiety-like behavior in rats after delayed, post-injury neuroimmune suppression.

Authors:  Krista M Rodgers; Yuetiva K Deming; Florencia M Bercum; Serhiy Y Chumachenko; Julie L Wieseler; Kirk W Johnson; Linda R Watkins; Daniel S Barth
Journal:  J Neurotrauma       Date:  2013-11-20       Impact factor: 5.269

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.